Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial

Patricia J. A. M. Brouwers*, Erik van Werkhoven, Harry Bartelink, Alain Fourquet, Claire Lemanski, Judith van Loon, John H. Maduro, Nicola S. Russell, Luc J. E. E. Scheijmans, Dominic A. X. Schinagl, Antonia H. Westenberg, Philip Poortmans, Liesbeth J. Boersma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Web of Science)

Abstract

Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after breast conserving therapy. Methods: From 2004 to 2011, 2421 cT1-2N0-2a breast cancer patients were randomised in the Young Boost Trial between a 16 and a 26 Gy boost to the tumour bed. Cosmesis was scored subjectively by the patient and physician, and objectively using BCCT.core, at baseline, one and four years after treatment. Presence of fibrosis, QoL and rib pain at four years were also scored. Data were complete for 864 patients. The relation between the separate components was investigated using a proportional odds model. Results: Of the 7 BCCT.core parameters, the distance from nipple to inframammary fold and the length of the breast contour were significantly related to the overall PRCO at four years. Patients with more fibrosis and poorer QoL scored their cosmesis worse, while rib pain was not related. The agreement between the different scores was low (kappa 0.26-0.42). Conclusion: The distance from nipple to inframammary fold, the length of the breast contour and the severity of fibrosis were the main factors related to patient-reported cosmetic outcome. Patients with better QoL scored their cosmesis better.
Original languageEnglish
Pages (from-to)107-113
JournalRadiotherapy and Oncology
Volume120
Issue number1
DOIs
Publication statusPublished - Jul 2016

Keywords

  • Breast conserving therapy
  • Cosmetic outcome
  • Patient reported outcome
  • Young patients
  • Young boost trial

Cite this